Next week, more than 10,000 will gather at McCormick Place in Chicago for the 2012 AAPS Annual Meeting and Exposition. AAPS marks an anniversary of sorts for me — it was the very first show I covered as an editor with Pharmaceutical Online. Each year since, the event has not disappointed, with impactful technical courses, as well as informative roundtables and symposiums. This year, I am especially looking forward to hearing the keynote speaker, best-selling author Rebecca Skloot, recount the story behind The Immortal Life of Henrietta Lacks, about a woman whose cells were taken without her permission after she died from cervical cancer in 1951. Although Henrietta’s cell line has left a legacy of scientific breakthroughs, which include the polio vaccine, in vitro fertilization, and various cancer treatments, the book opens up questions of bioethics. I’m also excited about this year’s hot topic sessions on staying successful in pharma, drug development, the FDA regulatory science initiative, and overcoming drug shortages. You can find all the important information in the AAPS digital program.
What trends and solutions do you want to see at AAPS?
Insights And Strategies
Designing Safety Into Size Reduction Equipment And Processes
By Scott Wennerstrum, Marketing and Technical Director, the Fitzpatrick Company
The evolution of size reduction equipment and processes in the pharmaceutical industry is one of gradual adaptation to meet higher standards of sanitation and safety. As requirements for sanitary processing, as defined by evolving cGMP standards, have become more stringent, manufacturers and the equipment makers who supply them have progressed to satisfy these requirements.
AAPS Booth 3531 Read more.
4 Reasons For The Rise In Blister Packaging
By Paul Dupont, Director of Business Development North America, Ropack, Inc.
Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments. In 2010, blister represented 17% of the global market and recorded $8.1B in revenue, according to Pharmaceutical Packaging Industry – 2011 Yearbook. GBI Research.
AAPS Booth 3630 Read more.
This podcast touches on one of the biggest drug development challenges that face biopharmaceutical companies today — the presence of unqualified impurities in their drug products. Dr. Clare Murray, Ph.D., of Scynexis, briefly discusses this problem and explains how this obstacle can be overcome. You can discuss this further with Scynexis at AAPS 2012, Booth 1839.
Innovation At Work
Application: Isolator Technology For Aseptic Processing
Uses of isolators for aseptic processing are far reaching. The earliest use of aseptic isolators was for sterility testing. Sterility test isolators account for the major part of aseptic isolator use and are available in many different sizes and configurations.
AAPS Booth 1602 Read more.
A Guide To IBC Blending And Handling Systems
With respect to the proper deployment of an intermediate bulk container (IBC) blending and handling system, it is always important to look closely into the handling of the IBCs from a before and after blending perspective. A comprehensive plan for IBC handling can optimize your process and eliminate inefficiencies.
AAPS Booth 3430 Read more.